Bimetallic ZIF nanoplatform for pH-responsive curcumin delivery: synthesis, characterization, and in vitro evaluation
Year: 2026
Type: article
Abstract: studies demonstrated that CBZIF maintained favorable biocompatibility toward normal L929 cells while exhibiting enhanced anticancer activity against C26 cancer cells compared with free CUR and pristine BZIF. Overall, these findings suggest that CBZIF is a promising nanoplatform for pH-responsive CUR delivery and provide a basis for further investigation of its potential biomedical applications.
Source: RSC Advances
DOI: 10.1039/d6ra08606c
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,042
OpenAlex ID: W7222971828
